-+ 0.00%
-+ 0.00%
-+ 0.00%

MindMaze Therapeutics Secures First CHF4 Million Tranche of Neuro.io Financing

MT Newswires·08/10/2026 01:25:57
Listen to the news
01:25 AM EDT, 08/10/2026 (MT Newswires) -- MindMaze Therapeutics (MMTX.SW) said Monday it completed the first tranche of its 8 million-franc strategic equity financing with Neuro.io, receiving 4 million francs in gross proceeds. The Swiss neurotherapeutics company transferred 4,970,000 treasury shares to Neuro.io and converted 2.9 million francs of mandatory convertible loan notes into 12,395,217 ordinary shares. The remaining 4 million francs are now expected to be funded in two installments in September and November under a revised schedule. The financing agreement and economic terms remain unchanged.